Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

September 2018 Issue of The Translational Scientist

View Issue

Register here to download any issue of The Translational Scientist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Outside the Lab Professional development

Another Man’s Treasure

| Kym Faull

Got an obsolete but working instrument sitting in the basement of your institution? Donate it!

Research Field Immunology

Not Immune to Damage

| Ruth Steer

Could activated T cells play a major role in driving neurodegeneration in glaucoma?

Research Field Drug discovery

Antibody About Turn

| Sam Cobb

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

Research Field Diagnostics & prognostics

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging.

Tools & Techniques Drug discovery

What Women Want

| Stephanie Sutton

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Research Field Neuroscience

The Pitter-Patter of Tiny Diagnoses

A simple yet accurate model could help streamline ROP screening

Disease Area Analytical science

Real-Time Tumor Analysis

| William Aryitey

MALDI and a SpiderMass device could save valuable surgery time

Research Field Cell & gene therapy

FDA Quackdown

| James Strachan

Regulators step in to stop stem cell clinics from marketing unproven therapies.

Research Field Neuroscience

The Matchmaker

| Paul Ursell

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Other issues of 2018